ResearcherCaris Life Sciences (United States)Active in the last 2 years

Sebastian Cole

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5138675711. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 8

Papers, trials and grants by year

2026: 1 paper

Papers 1

Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligence. Co-author DOI 10.1038/s41698-026-01543-6 ↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Harshabad Singh · 1 shared paper, 2026 · strength 0.24
- Paper Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligence. DOI 10.1038/s41698-026-01543-6 ↗
P. A. Philip · 1 shared paper, 2026 · strength 0.24
- Paper Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligence. DOI 10.1038/s41698-026-01543-6 ↗
David B. Spetzler · 1 shared paper, 2026 · strength 0.24
- Paper Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligence. DOI 10.1038/s41698-026-01543-6 ↗
Peter J. Hosein · 1 shared paper, 2026 · strength 0.24
- Paper Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligence. DOI 10.1038/s41698-026-01543-6 ↗
Tanios Bekaii‐Saab · 1 shared paper, 2026 · strength 0.24
- Paper Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligence. DOI 10.1038/s41698-026-01543-6 ↗
Igor A. Astsaturov · 1 shared paper, 2026 · strength 0.24
- Paper Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligence. DOI 10.1038/s41698-026-01543-6 ↗
Michael Jon Pishvaian · 1 shared paper, 2026 · strength 0.24
- Paper Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligence. DOI 10.1038/s41698-026-01543-6 ↗
Daniel D. Von Hoff · 1 shared paper, 2026 · strength 0.24
- Paper Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligence. DOI 10.1038/s41698-026-01543-6 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.